Litigation Details for Arbor Pharmaceuticals, LLC v. Lupin Limited (D. Del. 2020)
✉ Email this page to a colleague
Arbor Pharmaceuticals, LLC v. Lupin Limited (D. Del. 2020)
| Docket | ⤷ Try a Trial | Date Filed | 2020-07-08 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | |
| Jury Demand | Referred To | ||
| Patents | 9,066,936 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Arbor Pharmaceuticals, LLC v. Lupin Limited
The small molecule drugs covered by the patent cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for Arbor Pharmaceuticals, LLC v. Lupin Limited (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-07-20 | 67 | Order - -Memorandum and Order | three patents but only one term in one of those patents, U.S. Patent No. 9,066,936 (“the…the disputed claim term of U.S. Patent No. 9,066,936 (“the ’936 Patent”) is construed as follows: …reading the entire patent.” Id. at 1321 (internal quotation marks omitted). The patent specification…have reviewed the ’936 Patent and the excerpts of the ’936 Patent prosecution history submitted…ultimate question of the proper construction of the patent [is] a question of law,” although subsidiary fact-finding | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
